
E-Qure Corp. – OTC:EQUR
E-Qure Corp. stock price today
E-Qure Corp. stock price monthly change
E-Qure Corp. stock price quarterly change
E-Qure Corp. stock price yearly change
E-Qure Corp. key metrics
Market Cap | 6.90K |
Enterprise value | 161.31K |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | -0.22 |
Price/Sales | N/A |
Price/Book | -0.01 |
PEG ratio | N/A |
EPS | N/A |
Revenue | N/A |
EBITDA | -707.04K |
Income | -822.59K |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeE-Qure Corp. stock price history
E-Qure Corp. stock forecast
E-Qure Corp. financial statements
Dec 2020 | 0 | -200.95K | |
---|---|---|---|
Mar 2021 | 0 | -221.08K | |
Jun 2021 | 0 | -240.45K | |
Sep 2021 | 0 | -160.10K |
Dec 2020 | 81070 | 479.92K | 591.98% |
---|---|---|---|
Mar 2021 | 19428 | 508.00K | 2614.79% |
Jun 2021 | 13877 | 582.29K | 4196.08% |
Sep 2021 | 11500 | 610.37K | 5307.57% |
Dec 2020 | -131.66K | 0 | 26.29K |
---|---|---|---|
Mar 2021 | -184.81K | 0 | 121.04K |
Jun 2021 | -157.89K | 0 | 145.42K |
Sep 2021 | -43.83K | 0 | 39.92K |
E-Qure Corp. alternative data
Aug 2023 | 1 |
---|---|
Sep 2023 | 1 |
Oct 2023 | 1 |
Nov 2023 | 1 |
Dec 2023 | 1 |
Jan 2024 | 1 |
Feb 2024 | 1 |
Mar 2024 | 1 |
Apr 2024 | 1 |
May 2024 | 1 |
Jun 2024 | 1 |
Jul 2024 | 1 |
E-Qure Corp. other data
Period | Buy | Sel |
---|---|---|
May 2014 | 0 | 62380 |
Insider | Compensation |
---|---|
Mr. Itsik Ben Yesha (1953) Chief Technology Officer & Director | $168,590 |
Mr. Ohad Goren (1971) Chief Executive Officer & Director | $144,000 |
Mr. Gal Peleg (1978) Chief Financial Officer | $18,000 |
-
What's the price of E-Qure Corp. stock today?
One share of E-Qure Corp. stock can currently be purchased for approximately $0.
-
When is E-Qure Corp.'s next earnings date?
Unfortunately, E-Qure Corp.'s (EQUR) next earnings date is currently unknown.
-
Does E-Qure Corp. pay dividends?
No, E-Qure Corp. does not pay dividends.
-
How much money does E-Qure Corp. make?
E-Qure Corp. has a market capitalization of 6.90K.
-
What is E-Qure Corp.'s stock symbol?
E-Qure Corp. is traded on the OTC under the ticker symbol "EQUR".
-
What is E-Qure Corp.'s primary industry?
Company operates in the Healthcare sector and Medical Devices industry.
-
How do i buy shares of E-Qure Corp.?
Shares of E-Qure Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are E-Qure Corp.'s key executives?
E-Qure Corp.'s management team includes the following people:
- Mr. Itsik Ben Yesha Chief Technology Officer & Director(age: 72, pay: $168,590)
- Mr. Ohad Goren Chief Executive Officer & Director(age: 54, pay: $144,000)
- Mr. Gal Peleg Chief Financial Officer(age: 47, pay: $18,000)
-
How many employees does E-Qure Corp. have?
As Jul 2024, E-Qure Corp. employs 1 workers.
-
When E-Qure Corp. went public?
E-Qure Corp. is publicly traded company for more then 24 years since IPO on 13 Jul 2001.
-
What is E-Qure Corp.'s official website?
The official website for E-Qure Corp. is e-qure.com.
-
Where are E-Qure Corp.'s headquarters?
E-Qure Corp. is headquartered at 20 West 64th Street, New York, NY.
-
How can i contact E-Qure Corp.?
E-Qure Corp.'s mailing address is 20 West 64th Street, New York, NY and company can be reached via phone at +7 289167333.
E-Qure Corp. company profile:

E-Qure Corp.
e-qure.comOTC
1
Medical Devices
Healthcare
E-Qure Corp., a medical device company, focuses on the development and commercialization of bioelectrical signal therapy (BST) devices. Its BST devices implement patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure. The company was incorporated in 1988 and is based in New York, New York.
New York, NY 10023
CIK: 0001563536
ISIN: US26885P1093
CUSIP: 26885P109